Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
3.400
-0.250 (-6.85%)
At close: Jan 12, 2026, 4:00 PM EST
3.600
+0.200 (5.88%)
After-hours: Jan 12, 2026, 6:05 PM EST
LIXT Market Cap
LIXT has a market cap or net worth of $29.62 million as of January 12, 2026. Its market cap has increased by 530.25% in one year.
Market Cap
29.62M
Enterprise Value
28.74M
1-Year Change
530.25%
Ranking
Category
Stock Price
$3.40
Market Cap Chart
Since November 25, 2020, LIXT's market cap has decreased from $47.40M to $29.62M, a decrease of -37.51%. That is a compound annual growth rate of -8.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 20.80M | -7.14% |
| Dec 31, 2025 | 22.40M | 386.96% |
| Dec 31, 2024 | 4.60M | -13.21% |
| Dec 29, 2023 | 5.30M | -37.65% |
| Dec 30, 2022 | 8.50M | -48.17% |
| Dec 31, 2021 | 16.40M | -59.20% |
| Dec 31, 2020 | 40.20M | -15.19% |
| Nov 25, 2020 | 47.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |